Discover the latest in Wound Care

LINK News

Explore our new NEWS Section for the latest insights and updates in wound management.
Go to NEWS now!
LINK Scientific Content – Clinical Case Publication

Clinical assessment of a foam dressing containing growth factor enhancing hydrated polyurethanes

Scientific Content

Clinical assessment of a foam dressing containing growth factor enhancing hydrated polyurethanes

Type
Clinical Case Publication
Topics
Chronic Wounds, Biofilm, Epithelialization, Hydrated Polyurethanes, Leg Ulcer, Patient Quality of Life
Language
EN
Publication Year
2018
Author(s)
Jacek Mikosiński et al.
published in
Journal of Wound Care
Approx. reading time
50 min (12 pages)

Summary

Objective

This study assesses a novel dressing concept in venous leg ulcer (VLU) patients. It is based on boosting endogenous growth factor activities synthesised by functional granulation tissue.

Methods

Patients received treatment for eight weeks with a hydrated polyurethane-containing foam dressing plus concomitant compression therapy. Wound area reduction (WAR), percentage of wounds achieving a relative WAR of ≥40% and ≥60%, wound pain ratings for the last 24 hours and at dressing changes, EQ-5D Quality of Life questionnaire data, dressing handling and safety parameters were recorded.

Results

There were 128 patients who received treatment and data for 123 wound treatment courses were documented. Wound area size decreased from 13.3±9.8cm2 to 10.5±12.2cm2 at week eight and median relative WAR was 48.8%. At week eight, a relative WAR ≥40% was reached by 54.5% of the wounds, 41.5% reached a relative WAR of ≥60% and complete healing was observed in 13.5% of wounds. Median wound pain ratings (last 24 hours before dressing change) declined significantly from 30 to 15.5 (100 visual analogue scale [VAS], p=0.0001) and pain at dressing changes from 30 to 12.5 (p≤0.0001). The EQ-5D VAS rating increased from 58.4±19.2mm to 63.1±19.1mm (p=0.0059).

Conclusion

This clinical assessment shows that the concept of boosting endogenous growth factors through hydrated polyurethanes has the potential to accelerate WAR in VLU patients while decreasing pain levels and improving quality of life parameters.

Authors

Jacek Mikosiński et al.
MD, PhD, Poradnia Chorób Naczyn Obwodowych "MIKOMED", ul. Plugowa 51/53, 94-238, Poland; Joachim Dissemond

Read more about these topics

Get access to over 200 scientific abstracts, publications, webinars and E-learning to expand your knowledge of wound management.

You might be interested in